Rui Zhou
- Cancer Research top 1%
- MicroRNA in disease regulation 19
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 5%
- RNA modifications and cancer 11
- Circular RNAs in diseases 8
- Cancer-related gene regulation 6
- Wnt/β-catenin signaling in development and cancer 5
- Immunology top 10%
- Oncology top 5%
- Hepatology top 10%
-
- Ferroptosis and cancer prognosis 7
-
- Lichen and fungal ecology 5
- Journals
- Nucleic Acids Research (2 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Rui Zhou
85 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 1.4k
- Molecular Biology 1.8k
- Immunology 390
- Oncology 485
- Hepatology 78
Countries citing papers authored by Rui Zhou
This map shows the geographic impact of Rui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Zhou more than expected).
Fields of papers citing papers by Rui Zhou
This network shows the impact of papers produced by Rui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Zhou. The network helps show where Rui Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 7 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 83 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 17 | |
| 14 | METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent mannerbreakdown → | 2019 | 546 |
| 15 | 2018 | 34 | |
| 16 | 2017 | 67 | |
| 17 | 2017 | 74 | |
| 18 | 2015 | 12 | |
| 19 | ヒト胆管細胞においてICAM-1翻訳を抑制してインターフェロン-γ誘発性ICAM-1発現を調整するmiR-221 | 2010 | 1 |
| 20 | 2009 | 175 |
About Rui Zhou
Rui Zhou is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (19 papers), RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers), Ferroptosis and cancer prognosis (7 papers), Cancer-related gene regulation (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Lichen and fungal ecology (5 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (1.8k citations) and Immunology (390 citations). Rui Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xian‐Ming Chen, Guoku Hu, Qiang Lü, Haiwei Yang, Jie Han, Hongcheng Lu, Xiao Yang, Ji‐Fu Wei, Hao Yu and Wenbo Yuan. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.